Product Information
TOVIAZ ER 4 MG TABLET is a brand product labeled by Pfizer Inc., priced at $9.2623 per EA under NDC 00069024230. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Oct 31, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the fesoterodine fumarate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/1
Manufacturer
Pfizer Inc.NDC
00069024230
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FESOTERODINE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA022030FDA Approved
10/31/2008
TE Code
AB
On Market Since
10/31/2008
Price Statistics
The NADAC for TOVIAZ ER 4 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 70.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.2623 per EA |
|---|---|
| All-time high | $12.0342 (Nov 29, 2023) |
| All-time low | $5.4232 (Nov 28, 2013) |
| 52-week high | $9.2834 |
| 52-week low | $9.2561 |
| Median price | $9.5259 |
| Average price | $9.6630 |
| Largest weekly change | -23.0% (Dec 6, 2023) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOVIAZ ER 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOVIAZ ER 4 MG TABLET, manufactured by Pfizer Inc., is $9.2623 per EA (NDC 00069024230), effective Aug 19, 2026.
How has the price of TOVIAZ ER 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOVIAZ ER 4 MG TABLET has risen 70.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TOVIAZ ER 4 MG TABLET?
Since Nov 28, 2013, the NADAC for TOVIAZ ER 4 MG TABLET has ranged from a low of $5.4232 (Nov 28, 2013) to a high of $12.0342 (Nov 29, 2023), with a median of $9.5259 per EA.
Are there cheaper alternatives to TOVIAZ ER 4 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FESOTERODINE ER 4 MG TABLET, is $0.7909 per EA — about 91% below TOVIAZ ER 4 MG TABLET.
Who manufactures TOVIAZ ER 4 MG TABLET?
TOVIAZ ER 4 MG TABLET (NDC 00069024230) is labeled by Pfizer Inc., and CMS classifies it as a brand product.